Summary by Moomoo AI
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) FILED ITS LATEST SECURITIES MONTHLY CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 5 FEBRUARY 2024 COVERING THE SITUATION AS OF 31 JANUARY 2024. The report shows that the company's regulated/registered share capital remained unchanged during the month, with a total outstanding amount of 20,000,000,000 shares with a face value of $0.000025 per share, totaling $500,000. In addition, the Company's stock option plan changed during the month, with the number of stock options under the Initial Public Offering Option Plan increasing from 38,187,950 at the end of last month to 39,250,950, primarily due to the expiration of 234,000 share options. The company also carried out a share repurchase totaling 1,750,000 shares, which was completed on June 8, 2023. According to the report, all securities movements have been formally authorized by the Board of Directors and comply with relevant legal requirements.